Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Phase II Trial With Bevacizumab (Avastin) and Irinotecan (CPT-11) for Patients With Primary Brain Tumors and Progression After Standard Therapy

		Keywords:		Bevacizumab , Irinotecan

		Phase:		Phase 2

		Treatment ID#s:		VT1782 NCT00463203

		Age Group:		Adults Only

		Min Karnofsky Score:		Not Specified

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		08/18/2007

		Tumor Types:		Anaplastic Astrocytoma Any Malignant Brain Tumor Ependyoma Glioblastoma Multiforme Gliosarcoma Low Grade Glioma Meningioma Mixed Glioma Oligodendroglioma High Grade


		Comments:

		Treatment Type:		Chemotherapy Less-Toxics Immunological, Biological or Targeted Therapy.

		Contact:		Rigshospitalet Ulrik Lassen, MD., PH.D. Copenhagen, Denmark Phone: Click here to send an email

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By